Corresponding Author: Wilson M. Compton, MD, MPE, National Institute on Drug Abuse, 6001 Executive Blvd, MSC 9589, Bethesda, MD 20892-9589 (wcompton@nida.nih.gov).
Published Online: December 19, 2016. doi:10.1001/jama.2016.18900
Author Contributions: Dr Han had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Compton, Han, Hughes, Jones.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Compton, Han.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Han, Hughes, Jones.
Administrative, technical, or material support: Han.
Supervision: Han.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Compton reports ownership of stock in General Electric, 3M, and Pfizer. No other disclosures were reported.
Funding/Support: The National Survey on Drug Use and Health was supported by contracts from the Substance Abuse and Mental Health Services Administration. This study was jointly sponsored by the National Institute on Drug Abuse of the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, and the Office of the Assistant Secretary for Planning and Evaluation of the US Department of Health and Human Services.
Role of the Funder/Sponsors: The sponsors supported the authors who were responsible for preparation, review, and approval of the manuscript and the decision to submit the manuscript for publication. The sponsors had no role in the design and conduct of the study; analysis and interpretation of the data; preparation and review of the manuscript; or decision to submit the manuscript for publication. The sponsors reviewed and approved the manuscript.
Disclaimer: The findings and conclusions of this study are those of the authors and do not necessarily reflect the views of the National Institute on Drug Abuse of the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, or the US Department of Health and Human Services.
2.Lin
LA, Ilgen
MA, Jannausch
M, Bohnert
KM. Comparing adults who use cannabis medically with those who use recreationally.
Addict Behav. 2016;61:99-103.
PubMedGoogle ScholarCrossref 3.Chaudhry
HJ, Hengerer
AS, Snyder
GB. Medical board expectations for physicians recommending marijuana.
JAMA. 2016;316(6):577-578.
PubMedGoogle ScholarCrossref 5.Roy-Byrne
P, Maynard
C, Bumgardner
K,
et al. Are medical marijuana users different from recreational users?
Am J Addict. 2015;24(7):599-606.
PubMedGoogle ScholarCrossref 6.Schauer
GL, King
BA, Bunnell
RE, Promoff
G, McAfee
TA. Toking, vaping, and eating for health or fun.
Am J Prev Med. 2016;50(1):1-8.
PubMedGoogle ScholarCrossref